-
1
-
-
0020314517
-
Hepatobiliary disease in cystic fibrosis: A survey of current issues and concepts
-
Roy CC, Weber AM, Morin CL, Lepage G, Brisson G, Yousef I, et al. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J Pediatr Gastroenterol Nutr 1982;1:469-478.
-
(1982)
J Pediatr Gastroenterol Nutr
, vol.1
, pp. 469-478
-
-
Roy, C.C.1
Weber, A.M.2
Morin, C.L.3
Lepage, G.4
Brisson, G.5
Yousef, I.6
-
2
-
-
0020211196
-
Cystic fibrosis: Its influence on the liver, biliary tree, and bile salt metabolism
-
Isenberg JN. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism. Semin Liver Dis 1982;2:302-313.
-
(1982)
Semin Liver Dis
, vol.2
, pp. 302-313
-
-
Isenberg, J.N.1
-
5
-
-
0023864740
-
Liver disease and common-bile-duct stenosis in cystic fibrosis
-
Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med 1988;318:340-346.
-
(1988)
N Engl J Med
, vol.318
, pp. 340-346
-
-
Gaskin, K.J.1
Waters, D.L.2
Howman-Giles, R.3
De Silva, M.4
Earl, J.W.5
Martin, H.C.6
-
6
-
-
0028212786
-
Analysis of risk factors for the development of liver disease associated with cystic fibrosis
-
Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 1994;124:393-399.
-
(1994)
J Pediatr
, vol.124
, pp. 393-399
-
-
Colombo, C.1
Apostolo, M.G.2
Ferrari, M.3
Seia, M.4
Genoni, S.5
Giunta, A.6
-
7
-
-
0032770365
-
The evolution of liver disease in cystic fibrosis
-
Ling SC, Wilkinson JD, Hollman AS, McColl J, Evans TJ, Paton JY. The evolution of liver disease in cystic fibrosis. Arch Dis Child 1999;81:129-132.
-
(1999)
Arch Dis Child
, vol.81
, pp. 129-132
-
-
Ling, S.C.1
Wilkinson, J.D.2
Hollman, A.S.3
McColl, J.4
Evans, T.J.5
Paton, J.Y.6
-
8
-
-
0024424270
-
Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
-
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 [erratum: Science 1989;245:1437].
-
(1989)
Science
, vol.245
, pp. 1066-1073
-
-
Riordan, J.R.1
Rommens, J.M.2
Kerem, B.3
Alon, N.4
Rozmahel, R.5
Grzelczak, Z.6
-
9
-
-
0006294996
-
Erratum
-
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 [erratum: Science 1989;245:1437].
-
(1989)
Science
, vol.245
, pp. 1437
-
-
-
10
-
-
0026665209
-
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose-response study
-
Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. HEPATOLOGY 1992;16:924-930.
-
(1992)
Hepatology
, vol.16
, pp. 924-930
-
-
Colombo, C.1
Crosignani, A.2
Assaisso, M.3
Battezzati, P.M.4
Podda, M.5
Giunta, A.6
-
11
-
-
0027969208
-
Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: A randomized, placebo-controlled, crossover trial
-
Merli M, Bertasi S, Servi R, Diamanti S, Martino F, De Santis A, et al. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial. J Pediatr Gastroenterol Nutr 1994;19:198-203.
-
(1994)
J Pediatr Gastroenterol Nutr
, vol.19
, pp. 198-203
-
-
Merli, M.1
Bertasi, S.2
Servi, R.3
Diamanti, S.4
Martino, F.5
De Santis, A.6
-
12
-
-
19144371795
-
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial
-
The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis
-
Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. HEPATOLOGY 1996;23:1484-1490.
-
(1996)
Hepatology
, vol.23
, pp. 1484-1490
-
-
Colombo, C.1
Battezzati, P.M.2
Podda, M.3
Bettinardi, N.4
Giunta, A.5
-
13
-
-
0030989703
-
Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up
-
van de Meeberg PC, Houwen RH, Sinaasappel M, Heijerman HG, Bijleveld CM, Vanberge-Henegouwen GP. Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up. Scand J Gastroenterol 1997;32: 369-373.
-
(1997)
Scand J Gastroenterol
, vol.32
, pp. 369-373
-
-
Van De Meeberg, P.C.1
Houwen, R.H.2
Sinaasappel, M.3
Heijerman, H.G.4
Bijleveld, C.M.5
Vanberge-Henegouwen, G.P.6
-
14
-
-
0030847768
-
Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis
-
Scher H, Bishop WP, McCray PB Jr. Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis. Ann Pharmacother 1997;31:1003-1005.
-
(1997)
Ann Pharmacother
, vol.31
, pp. 1003-1005
-
-
Scher, H.1
Bishop, W.P.2
McCray Jr., P.B.3
-
15
-
-
0031049399
-
Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis
-
Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. HEPATOLOGY 1997;25:519-523.
-
(1997)
Hepatology
, vol.25
, pp. 519-523
-
-
Jacquemin, E.1
Hermans, D.2
Myara, A.3
Habes, D.4
Debray, D.5
Hadchouel, M.6
-
16
-
-
0031982747
-
A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease
-
Lindblad A, Glaumann H, Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. HEPATOLOGY 1998; 27:166-174.
-
(1998)
Hepatology
, vol.27
, pp. 166-174
-
-
Lindblad, A.1
Glaumann, H.2
Strandvik, B.3
-
17
-
-
0032878641
-
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease
-
Colombo C, Crosignani A, Battezzati PM, Castellani MR, Comi S, Melzi ML, et al. Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease. J Hepatol 1999;31: 672-677.
-
(1999)
J Hepatol
, vol.31
, pp. 672-677
-
-
Colombo, C.1
Crosignani, A.2
Battezzati, P.M.3
Castellani, M.R.4
Comi, S.5
Melzi, M.L.6
-
18
-
-
0035079090
-
Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease
-
Nousia-Arvanitakis S, Fotoulaki M, Economou H, Xefteri M, Galli-Tsinopoulou A. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. J Clin Gastroenterol 2001;32: 324-328.
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 324-328
-
-
Nousia-Arvanitakis, S.1
Fotoulaki, M.2
Economou, H.3
Xefteri, M.4
Galli-Tsinopoulou, A.5
-
19
-
-
84921431266
-
Ursodeoxycholic acid for cystic fibrosis-related liver disease
-
Cheng K, Ashby D, Smyth R. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev 2000;(2):CD000222.
-
(2000)
Cochrane Database Syst Rev
, Issue.2
-
-
Cheng, K.1
Ashby, D.2
Smyth, R.3
-
20
-
-
0014783008
-
Bile acid concentrations in serum during infancy and childhood
-
Sandberg DH. Bile acid concentrations in serum during infancy and childhood. Pediatr Res 1970;4:262-267.
-
(1970)
Pediatr Res
, vol.4
, pp. 262-267
-
-
Sandberg, D.H.1
-
21
-
-
0015917878
-
Malabsorption of bile acids in children with cystic fibrosis
-
Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973;289:1001-1005.
-
(1973)
N Engl J Med
, vol.289
, pp. 1001-1005
-
-
Weber, A.M.1
Roy, C.C.2
Morin, C.L.3
Lasalle, R.4
-
22
-
-
0018843162
-
Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis
-
Arborgh B, Eklund A, Norman A, Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1980;15:73-80.
-
(1980)
Scand J Gastroenterol
, vol.15
, pp. 73-80
-
-
Arborgh, B.1
Eklund, A.2
Norman, A.3
Strandvik, B.4
-
23
-
-
0021910146
-
Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis
-
Strandvik B, Samuelson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1985;20:381-384.
-
(1985)
Scand J Gastroenterol
, vol.20
, pp. 381-384
-
-
Strandvik, B.1
Samuelson, K.2
-
25
-
-
0025193141
-
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration
-
Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. HEPATOLOGY 1990; 12:322-334.
-
(1990)
Hepatology
, vol.12
, pp. 322-334
-
-
Nakagawa, M.1
Colombo, C.2
Setchell, K.D.R.3
-
26
-
-
0036095120
-
The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease
-
Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, et al. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol 2002;160: 1705-1715.
-
(2002)
Am J Pathol
, vol.160
, pp. 1705-1715
-
-
Lewindon, P.J.1
Pereira, T.N.2
Hoskins, A.C.3
Bridle, K.R.4
Williamson, R.M.5
Shepherd, R.W.6
-
27
-
-
0026072529
-
Classification of chronic viral hepatitis: A need for reassessment
-
Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
-
(1991)
J Hepatol
, vol.13
, pp. 372-374
-
-
Scheuer, P.J.1
-
28
-
-
0030028096
-
Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction
-
Rodrigues CM, Setchell KDR. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction. Biomed Chromatogr 1996;10:1-5.
-
(1996)
Biomed Chromatogr
, vol.10
, pp. 1-5
-
-
Rodrigues, C.M.1
Setchell, K.D.R.2
-
30
-
-
0028933933
-
Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children
-
Poupon R, Poupon RE. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 1995;66:1-15.
-
(1995)
Pharmacol Ther
, vol.66
, pp. 1-15
-
-
Poupon, R.1
Poupon, R.E.2
-
31
-
-
0027998655
-
Pharmacology of ursodeoxycholic acid, an enterohepatic drug
-
Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl 1994;204:1-15.
-
(1994)
Scand J Gastroenterol Suppl
, vol.204
, pp. 1-15
-
-
Hofmann, A.F.1
-
32
-
-
0027414207
-
Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria
-
Shoda J, Toll A, Axelson M, Pieper F, Wikvall K, Sjovall J. Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria. HEPATOLOGY 1993; 17:395-403.
-
(1993)
Hepatology
, vol.17
, pp. 395-403
-
-
Shoda, J.1
Toll, A.2
Axelson, M.3
Pieper, F.4
Wikvall, K.5
Sjovall, J.6
-
33
-
-
0036829089
-
The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors
-
Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 2002; 123:1649-1658.
-
(2002)
Gastroenterology
, vol.123
, pp. 1649-1658
-
-
Byrne, J.A.1
Strautnieks, S.S.2
Mieli-Vergani, G.3
Higgins, C.F.4
Linton, K.J.5
Thompson, R.J.6
-
34
-
-
0036828271
-
Functional expression of the canalicular bile salt export pump of human liver
-
Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002;123:1659-1666.
-
(2002)
Gastroenterology
, vol.123
, pp. 1659-1666
-
-
Noe, J.1
Stieger, B.2
Meier, P.J.3
-
35
-
-
0034949811
-
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver
-
Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121: 170-183.
-
(2001)
Gastroenterology
, vol.121
, pp. 170-183
-
-
Fickert, P.1
Zollner, G.2
Fuchsbichler, A.3
Stumptner, C.4
Pojer, C.5
Zenz, R.6
-
36
-
-
0036322124
-
Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP and preservation of BSEP activities
-
Paolini M, Pozzetti L, Montagnani M, Potenza G, Sabatini L, Antelli A, et al. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP and preservation of BSEP activities. HEPATOLOGY 2002;36:305-314.
-
(2002)
Hepatology
, vol.36
, pp. 305-314
-
-
Paolini, M.1
Pozzetti, L.2
Montagnani, M.3
Potenza, G.4
Sabatini, L.5
Antelli, A.6
-
37
-
-
0036725044
-
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
-
Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. HEPATOLOGY 2002;36:525-531.
-
(2002)
Hepatology
, vol.36
, pp. 525-531
-
-
Paumgartner, G.1
Beuers, U.2
-
38
-
-
0033172845
-
Review article: Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases
-
Trauner M, Graziadei IW. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 1999;13:979-996.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 979-996
-
-
Trauner, M.1
Graziadei, I.W.2
-
39
-
-
0022358795
-
Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis
-
Robb TA, Davidson GP, Kirubakaran C. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Gut 1985;26:1246-1256.
-
(1985)
Gut
, vol.26
, pp. 1246-1256
-
-
Robb, T.A.1
Davidson, G.P.2
Kirubakaran, C.3
-
40
-
-
0029126559
-
Ursodeoxycholate increases cytosolic calcium concentration and activates Cl-currents in a biliary cell line
-
Shimokura GH, McGill JM, Schlenker T, Fitz JG. Ursodeoxycholate increases cytosolic calcium concentration and activates Cl-currents in a biliary cell line. Gastroenterology 1995;109:965-972.
-
(1995)
Gastroenterology
, vol.109
, pp. 965-972
-
-
Shimokura, G.H.1
McGill, J.M.2
Schlenker, T.3
Fitz, J.G.4
-
41
-
-
0027325467
-
Abnormal expression of anion exchanger genes in primary biliary cirrhosis
-
Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993; 105:572-578.
-
(1993)
Gastroenterology
, vol.105
, pp. 572-578
-
-
Prieto, J.1
Qian, C.2
Garcia, N.3
Diez, J.4
Medina, J.F.5
-
42
-
-
0027293406
-
Intestinal bile acid malabsorption in cystic fibrosis
-
O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-1141.
-
(1993)
Gut
, vol.34
, pp. 1137-1141
-
-
O'Brien, S.1
Mulcahy, H.2
Fenlon, H.3
O'Broin, A.4
Casey, M.5
Burke, A.6
-
43
-
-
0027372350
-
Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats
-
Azer SA, Murray M, Farrell GC, Stacey NH. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats. HEPATOLOGY 1993;18:1224-1231.
-
(1993)
Hepatology
, vol.18
, pp. 1224-1231
-
-
Azer, S.A.1
Murray, M.2
Farrell, G.C.3
Stacey, N.H.4
-
44
-
-
0029879867
-
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease
-
Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol 1996;11:208-215.
-
(1996)
J Gastroenterol Hepatol
, vol.11
, pp. 208-215
-
-
Azer, S.A.1
Coverdale, S.A.2
Byth, K.3
Farrell, G.C.4
Stacey, N.H.5
|